Thursday, April, 18, 2019 08:31:01

Contribution By Ojaswita Kutepatil


Cognoa receives FDA breakthrough designation for its digital devices

These digital devices are the basis of Cognoa’s precision health platform. The FDA Breakthrough Device Program is envisioned to help patients in receiving timely access to advance technologies. Cognoa, Inc., the developer of AI-based personalized therapies and digital diagnostics, has reportedly announced that its first …

MeiraGTx and Janssen to develop gene therapies for IRD treatments

The latest transaction is the second significant collaboration by the two companies MeiraGTx Holdings Plc, a clinical-stage gene therapy company, has reportedly inked a strategic collaboration agreement with Janssen Pharmaceuticals, Inc., in a bid to develop and commercialize gene therapies for the IRD (inherited retinal …

CherryCircle Software raises $2.3m to advance its software innovations

 The investment round saw the participation of Hudson Park Capital, PLH Business Ventures, ATX Seed Ventures, and several other industry veterans.  CherryCircles’ software lets the pharma companies to capture development knowledge over time and handle risk across numerous dimensions with data. The US-based CherryCircle Software, …